Neovii Pharmaceuticals AG is an independent, global biopharmaceutical company with a patient-focused mission to develop and bring to market innovative therapies that transform lives, improving outcomes in transplantation medicine, hemato-oncological conditions, and immune disorders.

For over 8 years, Torus Pharma has distributed Grafalon in Romania, contributing to market development and ensuring patients and medical institutions have access to innovative treatment in transplantation and hemato-oncology. Our partnership with Neovii supports high medical standards and access to advanced therapy in Romania.